Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. UNH
stocks logo

UNH

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
113.42B
+12.52%
2.079
-69.47%
113.61B
+3.68%
6.556
-8.95%
113.51B
+1.7%
4.370
+7.11%
Estimates Revision
The market is revising Downward the revenue expectations for UnitedHealth Group Incorporated (UNH) for FY2025, with the revenue forecasts being adjusted by -0.12% over the past three months. During the same period, the stock price has changed by 5.74%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.12%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+0.4%
In Past 3 Month
Stock Price
Go Up
up Image
+5.74%
In Past 3 Month
Wall Street analysts forecast UNH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UNH is 393.95 USD with a low forecast of 260.00 USD and a high forecast of 440.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
21 Analyst Rating
Wall Street analysts forecast UNH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UNH is 393.95 USD with a low forecast of 260.00 USD and a high forecast of 440.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
17 Buy
3 Hold
1 Sell
Strong Buy
Current: 333.490
sliders
Low
260.00
Averages
393.95
High
440.00
Current: 333.490
sliders
Low
260.00
Averages
393.95
High
440.00
TD Cowen
Hold
maintain
$335 -> $338
2025-10-30
Reason
TD Cowen
Price Target
$335 -> $338
2025-10-30
maintain
Hold
Reason
TD Cowen raised the firm's price target on UnitedHealth to $338 from $335 and keeps a Hold rating on the shares. The firm updated its model as Q3 results checked a lot of boxes; adjusted EPS beat, FY25 guide raise, tax rate/investment income inline. They raise the target but keep the P/E target unchanged.
Bernstein
Lance Wilkes
Outperform
maintain
$433 -> $440
2025-10-30
Reason
Bernstein
Lance Wilkes
Price Target
$433 -> $440
2025-10-30
maintain
Outperform
Reason
Bernstein analyst Lance Wilkes raised the firm's price target on UnitedHealth to $440 from $433 and keeps an Outperform rating on the shares. The firm has updated its UnitedHealth EPS model post-Q3 earnings. Bernstein expects a sector-wide turnaround as MA and Medicaid recover from trough margins following MA rate shocks, withdrawal of competition, and redeterminations. The firm sees evidence that pricing discipline is being restored in MA and Optum Health, which will shock growth in the short-term but restore margin more swiftly. Bernstein sees UnitedHealth's valuation as attractive given its expectation for outsized EPS growth recovery over the next 4 years.
BofA
Neutral
maintain
$390 -> $410
2025-10-29
Reason
BofA
Price Target
$390 -> $410
2025-10-29
maintain
Neutral
Reason
BofA raised the firm's price target on UnitedHealth to $410 from $390 and keeps a Neutral rating on the shares. Q3 was "a little surprising" in that UHC margins outperformed while Optum Health and Insight both came in below expectations, the analyst tells investors. The "good news" is that UnitedHealth was able to handle the incremental investment and raised guidance by 25c, giving the firm more confidence that "it gave itself plenty of cushion" in its Q2 guidance reset, adds the analyst, who also raised the firm's estimates to reflect updated guidance.
Oppenheimer
Oppenheimer
Outperform
maintain
$325 -> $415
2025-10-29
Reason
Oppenheimer
Oppenheimer
Price Target
$325 -> $415
2025-10-29
maintain
Outperform
Reason
Oppenheimer raised the firm's price target on UnitedHealth to $415 from $325 and keeps an Outperform rating on the shares. The firm notes the company produced solid Q3 results, raising its outlook and reiterating most long-term targets. For MA, the outlook remains on track with prior comments, with 2026 margins expected to improve in 2026 and then return to the top-end of its 2%-4% target range by 2027. Meanwhile, OptumHealth expects margin improvement in 2026 as it rebounds toward long-term target margins of 6%-8%, Oppenheimer adds. Overall, the firm believes these results were a first positive step for UnitedHealth, which is setting more realistic goals as it looks to re-establish credibility with the Street.
RBC Capital
Ben Hendrix
Outperform
maintain
$286 -> $408
2025-10-29
Reason
RBC Capital
Ben Hendrix
Price Target
$286 -> $408
2025-10-29
maintain
Outperform
Reason
RBC Capital analyst Ben Hendrix raised the firm's price target on UnitedHealth to $408 from $286 and keeps an Outperform rating on the shares after its Q3 earnings beat. The management voiced confidence in pricing actions and plan exits driving margin expansion across the enterprise next year, the analyst tells investors in a research note. With expectations of margin improvement accelerating in 2027, UnitedHealth should see EPS growth near the low-end of its long-term annual EPS growth target of 13%-16%, the firm added.
UBS
Buy
maintain
$378 -> $430
2025-10-29
Reason
UBS
Price Target
$378 -> $430
2025-10-29
maintain
Buy
Reason
UBS raised the firm's price target on UnitedHealth to $430 from $378 and keeps a Buy rating on the shares. UnitedHealth sounded more confident on the growth trajectory for 2027 and beyond, the analyst tells investors in a research note.
See All Ratings

Valuation Metrics

The current forward P/E ratio for UnitedHealth Group Inc (UNH.N) is 20.25, compared to its 5-year average forward P/E of 20.60. For a more detailed relative valuation and DCF analysis to assess UnitedHealth Group Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
20.60
Current PE
20.25
Overvalued PE
23.84
Undervalued PE
17.36

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
14.45
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
16.35
Undervalued EV/EBITDA
12.56

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.19
Current PS
0.00
Overvalued PS
1.43
Undervalued PS
0.95
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

UNH News & Events

Events Timeline

(ET)
2025-12-03
08:20:00
Lifeward Receives Humana Medicare Approval for ReWalk 7
select
2025-12-02 (ET)
2025-12-02
14:10:00
UnitedHealth Shares Rise Modestly with Active Options Trading
select
2025-12-01 (ET)
2025-12-01
15:30:00
Mixed Options Sentiment in UnitedHealth (UNH) as Shares Drop $3.95
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
8.5
12-03PRnewswire
PinnedRoundhill Launches UNHW ETF, Expanding WeeklyPay™ Suite to 20 Stocks
  • Product Expansion: Roundhill Investments launched the UNHW ETF today, marking the 20th addition to the WeeklyPay™ series and its first foray into the healthcare sector, addressing strong investor demand for innovative ETFs.
  • Market Coverage: The new ETF will provide exposure to 20 single stocks, including AAPL, AMZN, and UNH, spanning six sectors, thereby enhancing portfolio diversity and flexibility for investors.
  • Investor Appeal: The introduction of the UNHW ETF is expected to attract more investors seeking innovative investment opportunities, further driving Roundhill's growth and influence in the ETF market.
  • Future Outlook: Roundhill plans to include UNHW in its WeeklyPay™ Universe ETF (WPAY) at the next scheduled rebalance, which will offer investors broader investment options and strengthen its competitive position in the market.
[object Object]
Preview
8.0
02:00 AMNASDAQ.COM
Significant Options Trading on Thursday: UNH, IVZ, JPM

  • Invesco Options Trading: Invesco Ltd (IVZ) experienced a significant options trading volume of 28,194 contracts, equating to about 2.8 million underlying shares, with notable activity in the $26 strike call option expiring January 16, 2026.

  • JPMorgan Options Trading: JPMorgan Chase & Co (JPM) saw an options trading volume of 46,461 contracts, representing approximately 4.6 million underlying shares, highlighted by the $315 strike call option expiring December 05, 2025.

  • Comparative Trading Volumes: The options trading volumes for both IVZ and JPM represent 66.4% and 58.5% of their respective average daily trading volumes over the past month.

  • Further Information: For additional details on available expirations for options on UNH, IVZ, or JPM, StockOptionsChannel.com can be visited.

[object Object]
Preview
8.0
12-04SeekingAlpha
Report: Republican Healthcare Plan to Feature Reforms for Pharmacy Benefit Managers

  • Republican Health Care Overhaul: A Republican plan to reform health care will focus on reducing the influence of pharmacy benefit managers (PBMs) to help control drug costs, with details to be discussed in a meeting led by House Speaker Mike Johnson.

  • Countering Subsidy Pressure: As Democrats push to extend enhanced ACA health insurance subsidies to 2026, Republicans aim to present their own bill and are advised to emphasize drug price reductions to counter potential backlash regarding subsidy cuts.

  • Key Pharmacy Benefit Managers: The three major PBMs involved in the discussion are UnitedHealth Group's OptumRx, Cigna's Express Scripts, and CVS Health's Caremark.

  • Public Sentiment on ACA Coverage: A poll indicates that 25% of individuals may drop their ACA insurance coverage if enhanced subsidies are not extended, highlighting the potential impact of subsidy changes on health insurance enrollment.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is UnitedHealth Group Inc (UNH) stock price today?

The current price of UNH is 333.49 USD — it has decreased -1.83 % in the last trading day.

arrow icon

What is UnitedHealth Group Inc (UNH)'s business?

UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health offers comprehensive and patient-centered care, addressing the physical, mental, social, and financial well-being. Optum Health delivers primary, specialty and surgical care; helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.

arrow icon

What is the price predicton of UNH Stock?

Wall Street analysts forecast UNH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UNH is 393.95 USD with a low forecast of 260.00 USD and a high forecast of 440.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is UnitedHealth Group Inc (UNH)'s revenue for the last quarter?

UnitedHealth Group Inc revenue for the last quarter amounts to 113.16B USD, increased 12.24 % YoY.

arrow icon

What is UnitedHealth Group Inc (UNH)'s earnings per share (EPS) for the last quarter?

UnitedHealth Group Inc. EPS for the last quarter amounts to 2.59 USD, decreased -60.22 % YoY.

arrow icon

What changes have occurred in the market's expectations for UnitedHealth Group Inc (UNH)'s fundamentals?

The market is revising Downward the revenue expectations for UnitedHealth Group Incorporated (UNH) for FY2025, with the revenue forecasts being adjusted by -0.12% over the past three months. During the same period, the stock price has changed by 5.74%.
arrow icon

How many employees does UnitedHealth Group Inc (UNH). have?

UnitedHealth Group Inc (UNH) has 400000 emplpoyees as of December 05 2025.

arrow icon

What is UnitedHealth Group Inc (UNH) market cap?

Today UNH has the market capitalization of 302.09B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free